Cms Cameron Mckenna Nabarro Olswang Llp opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Cms Cameron Mckenna Nabarro Olswang Llp

Patent Number:
Title:
Compositions Comprising A Delivery Agent And Preparation Thereof
Opposition Date:
Jun 13, 2024
Patent Number:
Title:
Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)
Opposition Date:
Oct 12, 2022
Patent Number:
Title:
Tablet Formulation Comprising A Peptide And A Delivery Agent
Opposition Date:
Jan 14, 2022
Patent Number:
Title:
Methods Of Treating Hepatic Encephalopathy
Opposition Date:
Aug 6, 2020
Patent Number:
Title:
Multiplex Assay For Improved Scoring Of Tumor Tissues Stained For Pd-L1
Opposition Date:
Oct 9, 2019
Patent Number:
Title:
Compositions Comprising A Delivery Agent And Preparation Thereof
Opposition Date:
Sep 26, 2019
Patent Number:
Title:
Methods, Kits, And Systems For Scoring The Immune Response To Cancer By Simultaneous Detection Of Cd3, Cd8, Cd20 And Foxp3
Opposition Date:
Jul 10, 2019
Patent Number:
Title:
Progranulin For Use In Treating Parkinson'S Disease Or Alzheimer'S Disease
Opposition Date:
Jul 3, 2019
Patent Number:
Title:
Methods And Compositions For The Targeted Modification Of A Genome
Opposition Date:
Oct 1, 2018

Competitors of Cms Cameron Mckenna Nabarro Olswang Llp

NOVO NORDISK A/S

VENTANA MEDICAL SYSTEMS, INC.

FRED HUTCHINSON CANCER CENTER

Want to track Cms Cameron Mckenna Nabarro Olswang Llp?

Feel free to send us a message here and we will get back to you